EV/EBITDA:
-12.24+0.34(+2.70%)Summary
- As of today (September 16, 2025), MLYS EV/EBITDA is -12.24, with a rise of +0.34 (+2.70%) during the most recent trading session on September 15, 2025.
- Over the past year, MLYS EV/EBITDA has dropped by -10.21 (-502.96%).
- MLYS EV/EBITDA is now -9515.38% below its all-time high of 0.13.
Performance
MLYS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLYS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.7% | -2.7% | -2.4% |
| 1 m1 month | -289.8% | +289.5% | +149.4% |
| 3 m3 months | -317.8% | +320.8% | +152.9% |
| 6 m6 months | -238.1% | +256.5% | +154.1% |
| ytdytd | -466.7% | +498.4% | +194.2% |
| 1 y1 year | -503.0% | +807.6% | +207.9% |
| 5 y5 years | - | - | - |
MLYS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.12 | -292.3% | -13.13 | +6.8% |
| 3 m | 3-month | -2.60 | -370.8% | -13.13 | +6.8% |
| 6 m | 6-month | -2.09 | -485.6% | -13.13 | +6.8% |
| 1 y | 1-year | -1.24 | -887.1% | -13.13 | +6.8% |
| 3 y | 3-year | 0.13 | -9515.4% | -28.10 | +56.4% |
| 5 y | 5-year | 0.13 | -9515.4% | -28.10 | +56.4% |
| alltime | all time | 0.13 | -9515.4% | -28.10 | +56.4% |
MLYS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -12.24(+466.7%) |
| Date | Value |
|---|---|
| 2024 | -2.16(+56.5%) |
| 2023 | -1.38 |
FAQ
- What is Mineralys Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Mineralys Therapeutics, Inc.?
- What is MLYS EV/EBITDA year-to-date change?
- What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Mineralys Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of MLYS is -12.24
What is the all time high EV/EBITDA for Mineralys Therapeutics, Inc.?
Mineralys Therapeutics, Inc. all-time high EV/EBITDA is 0.13
What is MLYS EV/EBITDA year-to-date change?
Mineralys Therapeutics, Inc. EV/EBITDA has changed by -10.08 (-466.67%) since the beginning of the year
What is Mineralys Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, MLYS EV/EBITDA has changed by -10.21 (-502.96%)